DNA adducts were quantified in hamster tracheas exposed to benzo(a)pyrene (BP) in organ culture, in basal as well as in non-basal cells, by in situ detection with an adduct-specific rabbit antiserum (W2/01) and with a mouse monoclonal antibody against human cytokeratins 5 and 8 (RCK102) to identify hamster trachea basal cells. Recognition by W2/01 of the adduct of (+)-anti-7,8-dihydmxy-9,lO-epoxide of BP (BP diolepoxide; BPDE) to deoxyguanosine (dG) was checked on human white blood ells (WBCs) exposed to BP together with 3-methylcholanthrene (3MC)-induced rat-liver miaosomes. By comparison with the adduct levels determined by 32P post-labeling, a lower detection limit of about 1 adduct per lo6 nucleotides could be deduced. Next, tracheal rings were exposed to BP (40 pM) in organ culture for 2 days, then washed and cultured without BP for another 3 days. At &ent time points epithelial cells were isolated and cytospin preparations made. Staining of BP DNA adducts combined with that of cytokeratin (both visualized with fluoresccnoe) allowed detection of adducts in both basal and non-basal cells in the same preparation. BP DNA adduct formation in basal and non-basal cells after 2 days of exposue to BP was not Werent. However, on r e m d of BP the adducts disappeared significantly faster from basal cells than from non-basal cells. The combination of the two antibodies mentioned above thus allows selective determination of BP DNA adduct levels in Werent cell types. This could be of importance with regard to the involvement of specific d types in the process of tumor initiation. (J€jj*stochem Cytochem 42:1427-1434, 1994) KEY WORDS: Hamster trachea; Basal cell; BP DNA adduct; Antiadduct antibody; Anti-cytokeratin antibody; Immunofluorescence microscopy; 32P post-labeling.
Introduction
Polycyclic aromatic hydrocarbons (PAH) form a group of widespread environmental pollutants (1). One major biological effect of these compounds is the formation of the so-called PAH DNA adducts, which are formed after covalent interaction of reactive PAH metabolites and nucleotides. Several methods aimed at the determination of the level of PAH DNA adducts have been developed. These include both biochemical (2-9) and immunochemical (10) (11) (12) (13) (14) (15) (16) (17) techniques. A widely used biochemical technique is the 32P postlabeling assay, which is renowned for its sensitivity (1 adduct in 1Olo nucleotides) and requires only pg amounts of DNA. This method, however, does not yield information on DNA adduct levels in different cell types in mixed populations. The immunochemical techniques are about three orders of magnitude less sensitive than the post-labeling method. However, the use of antibodies against DNA adducts offers the possibility of studying DNA ad- duct formation at the level of the single cell. Several groups (13, 14, 16, 17) reported the use of antibodies in in situ detection of benzo(a)pyrene (BP) DNA adducts. At our institute, a mouse monoclonal antibody (MAb), KE4, has been developed that recognizes BP DNA adducts (14) . It was applied both in in vitro studies, in which human fibroblasts (14) or white blood cells (WBCs) (16) were treated with the diolepoxide of BP, and in vivo studies (15) , in which bronchial cells were obtained from smoking individuals.
In the study presented here, we aimed at DNA adduct detection in specific cell types, i.e., the basal and non-basal cells of the hamster trachea. With respect to the role of specific cell types in the process of respiratory tract carcinogenesis, it is important to be able to measure adducts in these cell types. To this end, we combined immunocytochemical detection of adducts with identification of the cells of interest by use of another antiserum. For this purpose, the mouse MAb RCKlO2 was available, which was raised against human cytokeratins 5 and 8 but was shown to be specific also for basal cells of hamster trachea (18) . To facilitate the combination of both detection methods, the availability of non-mouse anti-adduct antibodies appeared desirable. For that reason the rabbit antiserum W2/01 was generated. Then a procedure was developed Human WBCs were cxposed to BP in the presence of 3-MC-induced rat liver microsomes for 5 hr at 37'C. The control consisted of an identical treatment without BP but with microsomes.
WBC DNA was pooled from three experiments. The total adduct levels are given in add/ 106n as determined by two independent post labeling assays 2 range of values. Adduct 1 comprised >9>% of the total adduct level.
Not detectable.
that enabled us both to determine the amount of BP D N A adducts per cell and to discriminate between basal and non-basal cells in one preparation, by use of immunofluorescence microscopy (IFM).
The use of only fluorescence markers in double-staining procedures instead of the combination of fluorescence and colorigenic substrates such as 3-amino-9-ethylcarbazole (AEC) and diaminobentidine (DAB) has specific advantages. The use of colorigenic substrates may result in precipitated products that are relatively unstable in alcoholic solutions (AEC) or are too intense, such that they obscure the fluorescence (DAB).
Interactive image processing of both adduct-specific and cell type-specific fluorescent images allowed the determination of the BP DNA adduct level in both basal and non-basal cells of hamster trachea. In an induction-repair experiment, hamster trachea rings were exposed to BP (40 WM) for 2 days. Thereafter, the tracheal rings were cultured for 3 more days in BP-free medium. Induction and disappearance of BP D N A adducts were determined in basal and non-basal cells of hamster tracheal epithelium.
Materials and Methods
Chemicals, Antibodies, and Enzymes. Bento(a)pyrene (BP). propidium iodide (PI), 4'.6-diamidino-2-phenylindole (DAPI). BSA, and RNAse A were obtained from Sigma (St Louis. MO), Y-[~~P]-ATF' (~1 1 0 TBqlmmol) was purchased from Amersham (Pwle, UK). DMSO and proteinase K were from Mcrck (Darmstadt, Germany). GaM-FITC was purchased from Southern Biotechnology Associates (Birmingham, AL.). GaR-FIE and GaR-TRITC were purchased from Kirkegaard & Perry (Gaithersburg, MD). RCK102 was purchased from Organon Teknika (Eindhoven, The Netherlands).
Treatment of WBCs with BP and Subsequent Post-labeling. Human
WBCs were collected and cxposed to BP (concentration from 0-100 pM; exposures in triplicate) for 5 hr in the presence of 3MC-induced rat liver microsomes as described before (19) . After cxposure the WBC were divided into two portions. One was processed for analysis by immunofluorescence microscopy (IFM) and from the other portion DNA was isolated for 32Ppostlabeling. WBC-DNA was subjected to the postlabeling assay as described by Gupta (8) . Briefly, 7.5 pg of DNA was digested with micrococcal endonuclease (Sigma: 33 mu/ pl) and spleen phosphodiesterase (Sigma: 0.67 mUlpI) in a total volume of 22.5 pl. After digestion, ammonium formate (final concentration 10 mM) and tetrabutyl ammonium chloride an equal volume of water. Next. 2 pI 200 mM Tris. pH 9.5, was added to the butanol fraction, which was then dried in vacuo in a Speed Vac. The residue was re-suspended in 25 pl of butanol and dried again. Finally, the digest was re-suspended in 3 p1 of Millipore-filtered water and labeled with Y-[~~P]-ATP (3000 Cilmmol; 1.7 MBq per sample) in the presence of polynucleotide kinase (New England Biolabs; Beverly, MA) (10 U/ pl; 3.9 U per sample) for 30 min at 37°C. The labeled nucleotides were separated by multidirectional chromatography on polyethyleneimine thin-layer sheets UT Baker; Phillipsburg, NJ). Adducts were quantified with the use of BP Polyclonal Antiserum W2l01. As a hapten to generate the polyclonal antibody W2lO1, untreated rat liver DNA was reacted with (e)-anti-BPdiolepoxide (Chemsyn; L e n a , KS). Next, the BP-modified DNA (modification level about 3%) was made single-stranded and complexed with methylated BSA (mBSA). A Flemish Giant rabbit (7 kg, 15 months of age) was immunized three times with 200 bg of BP DNA-mBSA intradermally at four places on the back. The first and second immunizations were given on Day 0 and Day 28 together with Freund's complete adjuvant; the third was given on Day 52 with Freund's incomplete adjuvant. The animal was bled three weeks after the final immunization. Serum was isolated and used without further purification.
Processing of WBCs for IFM. WBCs were fiied in methanokacetic acid (91) at room temperature (RT) and stored at -20'C. Before analysis, WBCs were put on multiwell slides (Kirkegaard & Perry) with a pipet and were processed as described by L.esko et al. (21) . with slight modifications. Slides with WBCs were rehydrated in 0.1 N HC1 at 4'C for 3 min, treated with RNAse A (0.1 mglml) for 1 hr at 37-C. and dehydrated in an ethanol series. To denature the DNA in situ, the slides were incubated in 0.15 N NaOH in 70% ethanol for 2 min at RT. To prevent rewinding of DNA, the slides were incubated in 3.5% formaldehyde (Riedel-de Haen; Seelze, Germany) in 70% ethanol for 30 sec and washed in 70% ethanol for 30 sec. Subsequent treatment with proteinase K (2 pglml) in 50 mM Tris-HC1, pH 7.4, 5 mM ED'WNa2 was for 10 min at 37'C. After washing, the preparations were pre-incubated with phosphate-buffered saline (PBS; 140 mM NaCI, 3 mM KCI. 8 mM NazHP04, 1.5 mM KH2P04, pH 7.4) containing 1% BSA (wlv) for 30 min at RT. Then the preparations were incubated with adduct-specific antibody (W2l01; 1:2000) for 18 hr at 4' C and with either F I E -or TRITC-labeled GaR IgG (1:75) for 1 hr at 37°C. All antibody dilutions were made in PBS containing 1% BSA (wlv). The cells were then counterstained in PI (50 nglml) in the case of FIX-labeled GaR IgG or DAPI (20 nglml) in the case of TRITC-labeled GaR IgG, mounted in glycerol-Tris-buffered saline (9:l). coverslipped, and examined by IFM.
Exposure of Hamster Tracheas to BP and Subsequent Processing for EM. Tracheas were isolated from eight Syrian golden hamsters and cultured as tracheal rings (four rings per trachea) as described by Wolterbeek et al. (22) . Starting on Day 0 (one day after isolation of the tracheas), tracheal rings were exposed to BP (40 pM) for 2 days. At the end of Day 2 the tracheal rings were transferred to BP-free medium and cultured for another 3 days. The medium was refreshed each day. At Day 2 (48-hr exposure to BP), Day 3 (24 hr after washing out BP), Day 4, and Day 5 , eight rings were removed. The epithelial cells were liberated from the cartilage by treatment with 0.05% trypsin in PBS containing 0.025% EDTA:Na2 for 24 hr at 4°C. After trypsinization, epithelial cells were suspended in FCS and cytospin preparations were made on aminosilane-pre-coated microscope slides. Next, the cells were fixed in methanol for 10 min at RT. Cells were rehydrated in 2 x SSC (300 mM NaCI, 30 mM Na-citrate, pH 7.0) at 37'C for 1 hr, treated with RNAse A (0.1 mglml) for 1 hr at 37'C. and dehydrated in an ethanol series. DNA denaturation and proteinase K treatment were as described above. After washing, the cytospin preparations were pre-incubated in TBS (20 mM Tris-HC1, pH 7.4, 150 mM NaCI) containing 5 % normal hamster serum (NHS) for 1 hr at RT. Then the preparations were incubated with W2lOl (k2000) for 18 hr at 4'C. Finally, the cells were washed and incubated successively with RCKlO2 (undiluted) for 1 hr at 37% GaR-TRITC (1:75) for 1 hr at 37'C, and GaM-FITC (1:75) for 1 hr at 37'C. All antibody dilutions were made in TBS containing 5% NHS. The cells were counterstained with DAPI (20 nglml), mounted in glycerol-TBS (9:1), coverslipped, and examined by IFM.
Image Recotding and Processing. For the recording of fluorescent images, two set-ups were used, i.e., a non-confocal scanning laser microscope (ISM) and a CCD (charge-coupled device) camera on top of a fluorescence microscope. Both systems are described in more detail below. 
Results
We describe the use of a procedure that allows detection ofBP DNA adducts in basal and non-basal cells of hamster trachea. A polyclonal rabbit antibody directed against BP-modified DNA was used. together with a mouse MAb specific for basal cells of hamster trachea epithelium. Both antigens were visualized by fluorescence.
First, the sensitivity of the rabbit antiserum W2/01 was tested in a model system in which human WBCs were exposed to various concentrations of BP (0-100 1 M ) in the presence of 3-MC-induced rat liver microsoma. After the incubations, WBCs were either used for isolation of DNA that was subjected to the 32P post-labeling procedure to assay adduct levels or processed for analysis by IFM. As can be seen in Table 1 , adduct levels in BP-treated W B G could be readily measured and ranged from 2.2 2 0.1 after treatment with 10 1M BP to 11.8 2 2.0 adducts/106 nucleotides (add/1O6n) after 100 pM BF! The adduct pattern. depicted in Figure 1A . shows one major spot (Adduct 1) that co-migrated with a reference adduct, i.e.. the adduct berween (+)-anti-BP-7,8-dihydrodioI-9,10epoxide and deoxyguanosine (BPDE-N2dG).
With both the FITCand the TRITC-labeled GaR conjugate as a second antibody, an increase in nuclear fluorescence could be observed with increasing concentration of BP (Figures 2A and 2B) . The nuclear fluorescence in WBG that had been treated with 10 1 M BP (resulting in 2.2 0.1 add/1O6n according to post-labeling data) was significantly higher than that in untreated WBCs with 
Table 2. Mean nuclear fluorescence 5 SD of basal and non-basal epithelial cells afer exposure of tracheal fings to BP (40 pM) for
nuclear fluorescence was about four times as high as that in untreated WBCs. The fluorescence data show a good correlation with the results of the adduct quantification by postlabeling ( Figure 2C ).
In the experiment with hamster trachea in organ culture, trachea rings were exposed to BP (40 pM) for 48 hr and kept in BPfree culture medium for another 3 days. A typical adduct pattern for 3*P post-labeling of DNA isolated from BP-exposed hamster trachea epithelial cells is depicted in Figure 1B . As previously shown 
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(22), the major DNA adduct formed during this treatment also co-migrates with BPDE-N2dG. Moreover, a few minor adducts, marked 2 and 4 in Figure 1B , could be detected. IFM analysis of the epithelial cells isolated from the exposed rings involved immunocytochemical staining of the cytokeratin of the basal cells. This procedure required fixation of the cells in a medium from which acetic acid was omitted, because this interfered with the subsequent staining. Therefore, methanol fixation was applied. As can be seen in Figure 3 , the use of the RCKlO2 antibody resulted mainly in perinuclear FITC staining. This FIX: image was used during interactive image processing to distinguish basal cells from non-basal cells.
In addition to this cell type-specific staining, DAPI staining was used to visualize the nuclear DNA and a TRITC stain to detect the adducts (Figure 3 ). The DAPI image was used to locate the nucleus containing the adduct-specific fluorescence (TRITC image). After interactive image processing the computer calculated the mean nuclear fluorescence per cell type ( Table 2 ). The data were also presented as histograms, in which the individual cells were grouped into classes of nuclear TRITC fluorescence (Figure 4 ). There was no significant difference in basal cells compared with non-basal cells with respect to the amount of BP DNA adducts after 48 hr of exposure to BP (Table 2 ). However, the subsequent disappearance of BP DNA adducts from basal cells was significantly faster than that from non-basal cells, as is clear from Table 2 and the histograms obtained on Day 3 (24 hr after removing BP; Student's t-test,) = 0.0295) and on Day 4 (48 hr after removing BP; Student's t-test,) = 0.0332). On Day 5 , 72 hr after removing BP, there no longer was a significant difference in BP DNA adduct level between the two cell types. However, a significant difference could still be observed with the nuclear fluorescence of the untreated epithelial cells, which indicates that BP DNA adducts are still present on Day 5 in both basal and non-basal cells.
Discussion
We developed a procedure that allowed quantification of BP DNA adducts in one specific cell type of the hamster tracheal epithelium, i.e., the basal cell. The procedure involves the use of two antibodies, one adduct-specific, i.e., rabbit antiserum W2/01, and one cytokeratin-specific, i.e., mouse MAb RCKlO2. After incubation of trachea rings with BP, cytospin preparations were made of epithelial cell isolates and each of the two antigens was stained by use of a fluorescent marker. Interactive image processing made it possible to determine the level of BP DNA adducts in basal and non-basal cells of the tracheal epithelium.
In the studies on the detection of BP DNA adduct levels in WBCs, the polyclonal rabbit antiserum W2/01 was shown to be well suited for application in IFM. The IFM data on adduct formation showed a good correlation with the respective post-labeling data, This was indeed expected, because the major adduct formed, BPDE-N2dG, was the adduct present in the BP-modified DNA against which the polyclonal antiserum had been raised. The lower detection limit reached with the rabbit antiserum for BP DNA adducts appeared to be 1 add/106n. This value agrees with the results of our previous studies with the mouse MAb ILE4 on human fibroblasts (14) and human WBCs (16) that had been treated with the (*)-anti-BP-diolepoxide. Van Schooten et al. (17) reported a lower detection limit of 7 add/lO8n for the immunocytochemical adduct detection with their rabbit antibody directed against BP DNA. Their quantification was based on peroxidase-anti-peroxidase/DAB staining as described by Scherer et al. (23) . In general, the lower detection limit of an immunofluorescence detection method is based on (a) the specificity and affinity of the antibody for the adduct, (b) the extent of nonspecific binding of the FITC or TRITC conjugate, and (c) the autofluorescence of the cells. The use of pre-immune serum instead of W2/01 as a negative control during in situ assays resulted in a nuclear fluorescence that was comparable to that of the control cells that had been incubated with W2101. Furthermore, there was a good correlation of staining with W2/01 and that with the established MAb II.E4. Therefore, it is reasonable to assume that autofluorescence is the main factor that determines the lower detection limit in this type of assay. This autofluorescence does not interfere with the detection of BP DNA adducts when DAB precipitation is used. In our double-staining procedure, however, the use of colorigenic substrates such as AEC or DAB would be impractical: the AEC-derived stain is relatively unstable towards the reaction conditions during DNA denaturation, and the use of DAB results in an intense staining that obscures the nuclear fluorescence (unpublished observations). Consequently, the use of two fluorescent markers was found to be the most suitable.
The BP DNA adduct levels in hamster trachea epithelial cells were determined in cytospin preparations rather than in frozen sections of the trachea. Use of the latter was avoided for two reasons. First, the morphology of frozen sections was found to deteriorate during processing of the section for IFM, which made it hard to obtain good-quality images. Second, because the preparation of frozen sections implies that cells are cut and nuclei are damaged, an unknown amount of DNA will be lost during the subsequent processing for IFM, which may introduce a substantial uncertainty as to the proportion of adducts still detectable. Cytospin slides, on the other hand, are made with intact cells, which maintain a good morphology. Making these preparations involves dissociation of the epithelial cells from the tracheal tissue by trypsinization; to avoid DNA repair, the trypsin treatment was done at 4°C. In earlier control experiments to determine the relative contribution of non-epithelial cells in the cytospin preparations, cells were stained with MAbs RCKlO2 and RGE53, which specifically recognize basal cells and mucous and ciliated cells, respectively (18) . It appeared that approximately 10% of the cells were not stained and therefore not of trachea epithelial origin. These contaminating cells may be fibroblasts, endothelial cells, granulocytes, or lymphocytes.
With regard to the number of BP DNA adducts fumed, it was surprising that there was no difference between basal and non-basal cells. From the work of Plopper et al. (24) , it is known that the secretory type of cell in the respiratory epithelium (i.e., the mucous cell in the hamster trachea) is the main site of cytochrome P450 activity, known to be required for BP activation. Therefore, it was reasonable to expect the highest BP DNA adduct level in the non-basal cell fraction. However, at the administered dose of BP (40 pM) this was not the case. This may be explained by intercellular transport of reactive BP metabolites. Ginsberg et al. (25) demonstrated that BP-diolepoxide is stable enough to be transported via the serum. Furthermore, the presence of conjugating enzymes should also be considered; relatively high GST-p levels in non-basal cells may reduce the formation of BP DNA adducts by conjugating the active BP-diolepoxide. The GST-p isoenzyme is known for its high affinity towards epoxides (26).
To avoid the occurrence of mutations, it is of vital importance for a cell to remove DNA adducts before entering into the S-phase of the cell cycle. The exact contribution of each cell type to the proliferation and differentiation of the tracheal epithelium is not known. The basal cell can give rise to all major cell types in the tracheal epithelium (27) . However, non-basal cells, such as the secretory cell (28) and the ciliated cell (29) , are also capable of dividing. In our study, the disappearance of BP DNA adducts from the basal cells was significantly faster than that from the non-basal cells. With respect to the role of the basal cell in cell renewal in tracheal epithelium, it may be of interest for the epithelium as a tissue to give preference to DNA repair in basal cells. However, on Day 5, 72 hr after removing BP, a considerable amount of adducts was still present also in basal cells. Most probably this is related to a reduction in repair capacity by that time, in accordance with results obtained in a previously published induction-repair experiment (30) .
The method described here offers the possibility to determine, at the cellular level, the amount of BP DNA adducts in a specific cell type. This is of great importance for studies on the relation between DNA damage and carcinogenesis, because in the process of carcinogenesis specific cell types are often involved. The amount of DNA damage in these specific cell types would therefore be far more relevant than the adduct level in the overall tissue, which is determined in the more common procedures using DNA isolated from homogenized tissue. Studies are now in progress in which hamster tracheas in organ culture are exposed to BP continuously. The development of squamous metaplasia and hyperplasia (precursors of neoplasia) is studied in this model system in relation to BP DNA adducts and cell proliferation in basal and non-basal cells.
